227 related articles for article (PubMed ID: 25595210)
1. Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion.
Yang XM; Cui L; White J; Kuck J; Ruchko MV; Wilson GL; Alexeyev M; Gillespie MN; Downey JM; Cohen MV
Basic Res Cardiol; 2015 Mar; 110(2):3. PubMed ID: 25595210
[TBL] [Abstract][Full Text] [Related]
2. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
[TBL] [Abstract][Full Text] [Related]
3. Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.
Yang XM; Cui L; Alhammouri A; Downey JM; Cohen MV
Cardiovasc Drugs Ther; 2013 Oct; 27(5):403-12. PubMed ID: 23832692
[TBL] [Abstract][Full Text] [Related]
4. Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts.
Yang XM; Liu Y; Cui L; Yang X; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):251-62. PubMed ID: 23233653
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.
Yang XM; Gadde S; Audia JP; Alvarez DF; Downey JM; Cohen MV
J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):371-376. PubMed ID: 30744423
[TBL] [Abstract][Full Text] [Related]
6. Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation.
Cohen MV; Yang XM; White J; Yellon DM; Bell RM; Downey JM
Cardiovasc Drugs Ther; 2016 Apr; 30(2):229-32. PubMed ID: 26780906
[TBL] [Abstract][Full Text] [Related]
7. The Highly Selective Caspase-1 Inhibitor VX-765 Provides Additive Protection Against Myocardial Infarction in Rat Hearts When Combined With a Platelet Inhibitor.
Yang XM; Downey JM; Cohen MV; Housley NA; Alvarez DF; Audia JP
J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):574-578. PubMed ID: 28399648
[TBL] [Abstract][Full Text] [Related]
8. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
[TBL] [Abstract][Full Text] [Related]
9. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model.
Dai W; Amoedo ND; Perry J; Le Grand B; Boucard A; Carreno J; Zhao L; Brown DA; Rossignol R; Kloner RA
Cardiovasc Drugs Ther; 2022 Apr; 36(2):217-227. PubMed ID: 33555510
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.
Barrabés JA; Inserte J; Mirabet M; Quiroga A; Hernando V; Figueras J; Garcia-Dorado D
Thromb Haemost; 2010 Jul; 104(1):128-35. PubMed ID: 20431845
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
[TBL] [Abstract][Full Text] [Related]
12. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
13. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury.
Lott FD; Guo P; Toombs CF
Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632
[TBL] [Abstract][Full Text] [Related]
14. Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.
Yang XM; Liu Y; Cui L; Yang X; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
Cardiovasc Drugs Ther; 2013 Apr; 27(2):109-15. PubMed ID: 23318690
[TBL] [Abstract][Full Text] [Related]
15. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
[TBL] [Abstract][Full Text] [Related]
16. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
[TBL] [Abstract][Full Text] [Related]
18. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
[TBL] [Abstract][Full Text] [Related]
19. Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.
Wang P; Zaragoza C; Holman W
Ann Thorac Surg; 2007 Mar; 83(3):1121-7. PubMed ID: 17307470
[TBL] [Abstract][Full Text] [Related]
20. Volatile anesthetics protect the ischemic rabbit myocardium from infarction.
Cope DK; Impastato WK; Cohen MV; Downey JM
Anesthesiology; 1997 Mar; 86(3):699-709. PubMed ID: 9066337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
